SBIR/STTR Research Award
SBIR TOPIC 109, PHASE I - TRANSCATHETER TRILEAFLET TRICUSPID SUTURE REPAIR SYSTEM
Award amount
$399,924Program and phase
SBIR · Phase IAward year
2020Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- TRANSMURAL SYSTEMS LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- NVTWAUS1JEH5
- Solicitation number
- Not reported
- Topic code
- 109
Research abstract
SBIR Topic 109, Transcatheter Trileaflet Tricuspid Suture Repair System:Primary and secondary tricuspid valve regurgitation can cause disabling right heart failure, hepatic dysfunction, cardiorenal syndrome, and death.Primary surgical repair or replacement is highly morbid, especially at the advanced stage of typical clinical presentation.Transcatheter repair using marketed and investigational clip-type devices is poorly suited for the trileaflet tricuspid valve.There is substantial unmet need.The goal of this project is to develop a catheter system to achieve a non-surgical off-pump tricuspid valve leaflet repair that allows three or more sutures to reappose three or more tricuspid valve leaflets to repair secondary or primary tricuspid valve regurgitation, sometimes described as “clover-leaf repair.”Under Phase I, the contractor will develop and test a functioning prototype system.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR TOPIC 107, PHASE II, TRANSCATHETER POTTS SHUNT
- SBIR TOPIC 112, FAST-TRACK, INTRAMYOCARDIAL SUTURE ANNULOPLASTY SYSTEM (""MIRTH"" AND ""SCIMITAR"" DEVICES)
- AWARD SBIR TOPIC #110 PHASE II-MRI MYOCARDIAL BIOPSY SYSTEM
- SBIR TOPIC 112, FAST-TRACK, INTRAMYOCARDIAL SUTURE ANNULOPLASTY SYSTEM (""MIRTH"" AND ""SCIMITAR"" DEVICES)
- Phase IIB Transmural Systems Transcatheter Cavopulmonary Bypass Endograft
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- SBIR Topic 109: Development of Monoclonal Antibody- Mediated Interventions to Combat Malaria
- Development of monoclonal antibody-mediated interventions to combat malaria
- Development of monoclonal antibody-mediated interventions to combat malaria
- Development of afucosylated monoclonal antibodies with enhanced effector functions to combat malaria
- Multi-path DCS as a novel non-invasive treatment for amyotrophic lateral sclerosis
Research funding history
21 SBIR/STTR records share this UEI (2015–2023). Reported award amounts total $36,729,432. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services